Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The current ratio is N/A as of Tuesday, October 6, 2026.
CURRENT RATIO
N/A
Market Cap
$225.24M
Current Ratio
10.14
TTM Avg
15.36
3Y Avg
19.42
5Y Avg
27.25
Market Cap
$231.77M
Current Ratio
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$220.93M
Current Ratio
6.45
TTM Avg
11.52
3Y Avg
11.11
5Y Avg
13.89
Market Cap
$235.08M
Current Ratio
48.62
TTM Avg
31.63
3Y Avg
25.23
5Y Avg
22.81
Market Cap
$235.66M
Current Ratio
1.43
TTM Avg
1.27
3Y Avg
1.29
5Y Avg
1.36
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Vogenx Inc. (VOGX) | $227.91M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $227.60M | 2.85 | 2.31 | 2.04 | 2.06 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $225.24M | 10.14 | 15.36 | 19.42 | 27.25 |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | 2.96 | 4.51 | 4.52 | 4.67 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | 1.54 | 1.17 | 19.33 | 29.22 |
| InflaRx N.V. (IFRX)vs › | $232.72M | 8.22 | 4.59 | 5.79 | 6.14 |
| Profound Medical Corp. (PROF)vs › | $220.93M | 6.45 | 11.52 | 11.11 | 13.89 |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 48.62 | 31.63 | 25.23 | 22.81 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.66M | 1.43 | 1.27 | 1.29 | 1.36 |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | 21.72 | 10.47 | 8.50 | 9.09 |
Current Ratio
N/A
Quick Ratio
N/A
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
